PP
BIIB icon

Palladium Partners’s Biogen BIIB Stock Holding History

Palladium Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,351
Closed -$383K – 253
2020
Q3 		$383K Sell
1,351
-83
-6% -$23.1K 0.02% 200
2020
Q2 		$384K Sell
1,434
-44
-3% -$13.2K 0.03% 195
2020
Q1 		$468K Sell
1,478
-519
-26% -$158K 0.04% 178
2019
Q4 		$593K Buy
+1,997
New +$554K 0.04% 191
2019
Q3 		– Sell
-20,287
Closed -$4.74M – 251
2019
Q2 		$4.74M Buy
20,287
+2,781
+16% +$642K 0.33% 84
2019
Q1 		$4.14M Buy
+17,506
New +$5.51M 0.3% 83

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Palladium Partners's BIIB Position: Q4 2020 in Review

Palladium Partners sold out of Biogen (BIIB) in Q4 2020, closing a stake of 1,351 shares — an estimated $383K sold.

Palladium Partners first reported a position in BIIB in Q1 2019 and held it in 6 quarters. The position peaked at $4.74M in Q2 2019. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Palladium Partners reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Palladium Partners sold 1,351 Biogen shares in Q4 2020, an estimated $383K.
  • Palladium Partners first reported a position in Biogen in Q1 2019 and held it in 6 quarters.
  • Palladium Partners's Biogen position peaked at $4.74M in Q2 2019.
  • 1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Palladium Partners's 13F filing for Q4 2020, filed 29 Jan 2021.